Molecular genetics underpins precision diagnostics across inherited disease, oncology, reproductive health, and pharmacotherapy. At Southern Medical Supplies Limited (SMSL), we deliver end-to-end molecular genetics solutions—from high-quality DNA/RNA extraction to qPCR/dPCR, Sanger sequencing, targeted NGS panels (e.g., hereditary cancer, cardiomyopathy, neuromuscular, epilepsy), exome-level analyses, mitochondrial genome testing, CNV detection (MLPA, array CGH/SNP microarray), repeat-expansion assays (e.g., FMR1, C9orf72), pharmacogenomics (e.g., CYP2C19, CYP2D6, SLCO1B1), HLA typing, and carrier/prenatal screening—supported by validated controls, robust pre-analytics, and clear clinical reporting aligned to ACMG/AMP guidance. Our portfolio spans molecular, sequencing, and microarray workflows sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the analytical sensitivity, specificity, and reproducibility clinicians need for confident diagnosis and personalized care.